WallStreetZenWallStreetZen

NASDAQ: STOK
Stoke Therapeutics Inc Stock Ownership - Who owns Stoke Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Stoke Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Jonathan AllanGENERAL COUNSEL CORP SEC2026-06-161,457$29.95
$43.64kSell
Barry TichoCHIEF MEDICAL OFFICER2026-06-011,795$30.58
$54.89kSell
Barry TichoCHIEF MEDICAL OFFICER2026-05-012,243$32.79
$73.55kSell
Barry TichoCHIEF MEDICAL OFFICER2026-04-011,838$32.66
$60.03kSell
Jonathan AllanGENERAL COUNSEL CORP SEC2026-03-208,692$33.64
$292.36kSell
Jonathan AllanGENERAL COUNSEL CORP SEC2026-03-20601$34.41
$20.68kSell
Barry TichoCHIEF MEDICAL OFFICER2026-03-191,461$29.99
$43.82kSell
Barry TichoCHIEF MEDICAL OFFICER2026-03-191,365$2.19
$2.99kBuy
Jason HoittChief Patient Officer2026-03-1830$32.85
$985.50Sell
Barry TichoCHIEF MEDICAL OFFICER2026-03-18103$32.85
$3.38kSell

1 of 10

STOK insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when STOK insiders and whales buy or sell their stock.

STOK Shareholders

What type of owners hold Stoke Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Seth Loring Harrison54.51%33,948,426$1.05BInsider
Apple Tree Partners IV LP27.56%17,161,713$532.01MInsider
Rtw Investments LP9.03%5,623,525$174.33MInstitution
Blackrock Inc8.65%5,385,714$166.96MInstitution
Fmr LLC8.64%5,383,666$166.89MInstitution
Lynx1 Capital Management LP7.65%4,763,673$147.67MInstitution
Redmile Group LLC6.69%4,164,120$129.09MInstitution
Trust Skorpios6.27%3,906,181$121.09MInsider
Rtw Investments LP5.69%3,544,248$109.87MInsider
Morgan Stanley5.50%3,423,280$106.12MInstitution

1 of 3

STOK vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
STOK54.32%45.68%Net SellingNet Selling
HRMY78.99%21.01%Net SellingNet Selling
ADMA79.04%20.96%Net SellingNet Buying
NUVB58.01%41.99%Net BuyingNet Buying
LKFT47.44%0.00%
View Top Biotech Stocks

Stoke Therapeutics Stock Ownership FAQ

Who owns Stoke Therapeutics?

Stoke Therapeutics (NASDAQ: STOK) is owned by 114.17% institutional shareholders, 96.01% Stoke Therapeutics insiders, and 0.00% retail investors. Seth Loring Harrison is the largest individual Stoke Therapeutics shareholder, owning 33.95M shares representing 54.51% of the company. Seth Loring Harrison's Stoke Therapeutics shares are currently valued at $1.05B.

If you're new to stock investing, here's how to buy Stoke Therapeutics stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.